We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
476
Intel
INTC
$513B
$455K 0.07%
+9,129
New +$446K
MCFT icon
477
MasterCraft Boat Holdings
MCFT
$590M
$454K 0.07%
18,262
-4,198
-19% -$93.6K
TTC icon
478
Toro Company
TTC
$9.49B
$454K 0.07%
4,782
-8,266
-63% -$731K
TMHC
479
DELISTED
Taylor Morrison
TMHC
$452K 0.07%
+17,629
New +$449K
NSP icon
480
Insperity
NSP
$2.01B
$451K 0.07%
+5,543
New +$455K
UFPI icon
481
UFP Industries
UFPI
$5.19B
$451K 0.07%
8,127
-26,386
-76% -$1.45M
VNRX icon
482
VolitionRx Ltd
VNRX
$9.34M
$451K 0.07%
5,797
+134
+2% +$9.22K
CBUS icon
483
Cibus
CBUS
$138M
$449K 0.07%
2,126
+1,887
+790% +$382K
NHC icon
484
National Healthcare
NHC
$3.38B
$448K 0.07%
+6,742
New +$444K
AGYS icon
485
Agilysys
AGYS
$3.06B
$447K 0.07%
11,648
-3,251
-22% -$108K
RTH icon
486
VanEck Retail ETF
RTH
$263M
$447K 0.07%
+2,847
New +$440K
EME icon
487
Emcor
EME
$36B
$446K 0.07%
4,877
-14,213
-74% -$1.14M
IEP icon
488
Icahn Enterprises
IEP
$5.3B
$446K 0.07%
+8,797
New +$448K
BBW icon
489
Build-A-Bear
BBW
$462M
$444K 0.07%
+103,992
New +$400K
BC icon
490
Brunswick
BC
$5.28B
$444K 0.07%
5,823
+1,042
+22% +$73.5K
KSS icon
491
Kohl's
KSS
$2.19B
$444K 0.07%
+10,900
New +$317K
LPX icon
492
Louisiana-Pacific
LPX
$5.49B
$444K 0.07%
11,933
-15,933
-57% -$534K
XLK icon
493
State Street Technology Select Sector SPDR ETF
XLK
$123B
$444K 0.07%
+6,830
New +$416K
OVID icon
494
Ovid Therapeutics
OVID
$491M
$443K 0.07%
191,833
+134,959
+237% +$629K
BJRI icon
495
BJ's Restaurants
BJRI
$1.48B
$442K 0.07%
11,484
-6,388
-36% -$218K
CCI icon
496
Crown Castle
CCI
$32.2B
$442K 0.07%
+2,776
New +$450K
CHX
497
DELISTED
ChampionX
CHX
$441K 0.07%
28,804
+4,918
+21% +$54.6K
AVID
498
DELISTED
Avid Technology Inc
AVID
$441K 0.07%
+27,815
New +$311K
ABNB icon
499
Airbnb
ABNB
$107B
$440K 0.07%
+3,000
New +$443K
INSM icon
500
Insmed
INSM
$28.6B
$440K 0.07%
13,224
-75,805
-85% -$2.77M

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.